Citronellol

Citronellol

SCHEMBL301394

CC(C)=CCC[C@H](C)CCO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 4/20 1.00
ALDH1A1 P00352 1/20 1.00
TSHR P16473 1/20 0.45
USP2 O75604 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
SQLE Q14534 3/20 0.40
NFE2L2 Q16236 1/20 0.39
MEN1 O00255 1/20 0.38
CYP3A4 P08684 1/20 0.38
KMT2A Q03164 1/20 0.38
GGPS1 O95749 2/20 0.37
FDPS P14324 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(+)-Citronellol SCHEMBL21321 1.00 ALOX15 (1.00) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellol SCHEMBL21320 1.00 ALOX15 (1.00) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellol SCHEMBL1871004 1.00 ALOX15 (1.00) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellol SCHEMBL18301310 1.00 ALOX15 (1.00) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellol SCHEMBL17688817 0.98 ALOX15 (0.95) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellol SCHEMBL28002434 0.98 ALOX15 (0.95) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellol SCHEMBL11351853 0.98 ALOX15 (0.95) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellol SCHEMBL30222407 0.98 ALOX15 (0.95) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellol SCHEMBL30843841 0.98 ALOX15 (0.95) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellol SCHEMBL8758931 0.96 ALOX15 (0.91) ALOX15ALDH1A1TSHRUSP2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 700 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250344991-A1 COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION UNIV ROCKEFELLER (US) 2025-11-13 US claimed
WO-2025202181-A1 TERPENOID COMPOSITIONS AND BLENDS THEREOF EVODIABIO APS (DK) 2025-10-02 WO claimed
US-20250302678-A1 ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS PROCTER & GAMBLE (US) 2025-10-02 US claimed
EP-3648613-B1 COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION UNIV ROCKEFELLER (US) 2025-09-24 EP claimed
US-12350136-B2 Absorbent articles including perfume and cyclodextrins THE PROCTER & GAMBLE COMPANY (US) 2025-07-08 US claimed
CN-119816452-A Freshness enhancement labels, sheets, and pouches RYP实验室有限公司 2025-04-11 CN claimed
WO-2025051371-A1 A FRAGRANCE PASTILLE SYMRISE AG (DE) 2025-03-13 WO claimed
WO-2025045354-A1 A FRAGRANCE TABLET SYMRISE AG (DE) 2025-03-06 WO claimed
WO-2025045353-A1 A FRAGRANCE POD SYMRISE AG (DE) 2025-03-06 WO claimed
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety THE PROCTER & GAMBLE COMPANY (US) 2025-02-25 US claimed
US-11299717-B2 Production of citronellal and citronellol in recombinant hosts EVOLVA SA (SE) 2022-04-12 US claimed
US-20220064191-A1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2022-03-03 US claimed
US-20190225945-A1 PRODUCTION OF CITRONELLAL AND CITRONELLOL IN RECOMBINANT HOSTS EVOLVA SA (SE) 2019-07-25 US claimed
WO-2018145219-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING SERANI MOSTAZAL JORGE (CL) 2018-08-16 WO claimed
WO-2018069418-A2 PRODUCTION OF CITRONELLAL AND CITRONELLOL IN RECOMBINANT HOSTS EVOLVA SA (CH) 2018-04-19 WO claimed
EP-3197507-A1 MALODOR REDUCTION COMPOSITIONS The Procter and Gamble Company (US) 2017-08-02 EP claimed
WO-2016049389-A1 MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
US-20070190177-A1 Zinc composition and their use in anti-microbial applications SWISS-AMERICAN PRODUCTS, INC. 2007-08-16 US claimed
EP-1048687-A1 Powdered water soluble polymers INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2000-11-02 EP claimed
US-5403739-A Resolution of a racemic mixture using a fatty acid, followed by hydrolysis and recovery JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) 1995-04-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety SMS, SRM, AAAS ALOX15 2826/4885ALDH1A1 3361/4885TSHR 3016/4885
US-20220064191-A1 SILICONE COMPOUNDS SMCHD1, SRI, SMS ALOX15 2271/4885ALDH1A1 3917/4885TSHR 3842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.